Fiscal Year End Company Status Exempt Flag November 30 Delist N Incorporation Locations Inc. Date Expiry Date Country Region Description 17/May/2007  3/Aug/2020  Canada      Exchange Filing Office Location (not available)		Business Type(s) Primary/Secondary Business Type Details Primary  *Research and Development of Pharmaceutical Products  (not available)  Securities Symbol Security Name Market Status *TBP *Tetra Bio-Pharma Inc. TSX Venture DELIST *TBP.WT *Tetra Bio-Pharma Inc. wt ex 05Mar2021 TSX Venture DELIST *TBP.WT.A *Tetra Bio-Pharma Inc wt 12jul2022 TSX Venture DELIST *TBP.WT.B *Tetra Bio-Pharma Inc wt 13Feb2023 TSX Venture DELIST Name History From To *Tetra Bio-Pharma Inc. 16/Mar/2017 3/Aug/2020 Company Facts Reconciliation Subject Date Returned (not available) Associations Auditing Firm:  *UHY McGovern Hurley LLP Transfer Agent:  *Computershare Investor Services Inc.
Latest Information Type Date Title News Releases  30/Jul/2020  NEWS RELEASE - TETRA BIO-PHARMA ANNOUNCES EXPECTED EFFECTIVE DATE OF LISTING ON TSX OF ITS COMMON SHARES AND WARRANTS[CANADA NEWSWIRE]     NEWS RELEASE - TETRA AND MONDIAS JOINTLY ANNOUNCE THE ACQUISITION OF TETRA'S SUBSIDIARY LUMIERA BY MONDIAS TO CREATE A NEW GROWTH PLATFORM[CANADA NEWSWIRE]     NEWS RELEASE - TETRA BIO-PHARMA ANNOUNCES CLOSING OF PUBLIC OFFERING[CANADA NEWSWIRE] Bulletins  30/Jul/2020  Delist Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data